qPULA Trading Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,825
Closed -$717K 232
2021
Q4
$717K Buy
+2,825
New +$826K 1.28% 15
2021
Q3
Sell
-2,933
Closed -$689K 208
2021
Q2
$689K Buy
+2,933
New +$524K 1.23% 20
2021
Q1
Sell
-2,700
Closed -$282K 161
2020
Q4
$282K Buy
+2,700
New +$273K 0.51% 70

Other funds holding MRNA

qPULA Trading Management's MRNA Position: Q1 2022 in Review

qPULA Trading Management sold out of Moderna (MRNA) in Q1 2022, closing a stake of 2,825 shares — an estimated $717K sold.

qPULA Trading Management first reported a position in MRNA in Q4 2020 and held it in 3 quarters. The position peaked at $717K in Q4 2021. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • qPULA Trading Management reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • qPULA Trading Management sold 2,825 Moderna shares in Q1 2022, an estimated $717K.
  • qPULA Trading Management first reported a position in Moderna in Q4 2020 and held it in 3 quarters.
  • qPULA Trading Management's Moderna position peaked at $717K in Q4 2021.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on qPULA Trading Management's 13F filing for Q1 2022, filed 13 May 2022.